Jorey Chernett - 06 Nov 2026 Form 4 Insider Report for Starling Oncology, Inc. (STLN)

SEC form
4
Accepted by SEC
10 Nov 2026, 18:33:14 UTC
Prior SEC filing
02 Nov 2026
Next SEC filing
12 Nov 2026
Source filing
View source filing
Filing notes and source

Key filing fact

Jorey Chernett filed Form 4 for Starling Oncology, Inc. (STLN) on 10 Nov 2026.

Key facts

  • This page summarizes Jorey Chernett's Form 4 filing for Starling Oncology, Inc. (STLN).
  • 6 reported transactions and 4 derivative rows are listed below.
  • Accepted by SEC: 10 Nov 2026, 18:33.

Change

  • Previous filing in this sequence was filed on 02 Nov 2026.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002042077 Primary reporting owner

Chernett Jorey

Relationship
10%+ Owner

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

STLN transaction

Common Stock

Sale

Transaction value
Shares
-2,851,061
Change %
-27%
Price
$3.99*
Shares after
7,809,797
Date
06 Nov 2026
Ownership
Direct
Footnotes
F1, F2
STLN transaction

Common Stock

Purchase

Transaction value
Shares
+48,294
Change %
+0.62%
Price
$3.65*
Shares after
7,858,091
Date
09 Nov 2026
Ownership
Direct
Footnotes
F2, F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

STLN transaction Derivative

Call Option (STLN 20NOV26 $4C)

Purchase

Transaction value
Shares
+10,000
Change %
Price
$0.0750*
Shares after
10,000
Date
06 Nov 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,000,000
Exercise price
$4.00
Footnotes
F2
STLN transaction Derivative

Call Option (STLN 19FEB27 $4C)

Purchase

Transaction value
Shares
+5,000
Change %
Price
$0.4000*
Shares after
5,000
Date
06 Nov 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
500,000
Exercise price
$4.00
Footnotes
F2
STLN transaction Derivative

Call Option (STLN 19FEB27 $5C)

Purchase

Transaction value
Shares
+7,500
Change %
Price
$0.5357*
Shares after
7,500
Date
09 Nov 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
750,000
Exercise price
$5.00
Footnotes
F2, F4
STLN transaction Derivative

Call Option (STLN 21MAY27 $5C)

Purchase

Transaction value
Shares
+7,000
Change %
Price
$0.6700*
Shares after
7,000
Date
10 Nov 2026
Ownership
Direct
Underlying class
Common Stock
Underlying amount
700,000
Exercise price
$5.00
Footnotes
F2
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 4 footnotes

Footnote F1

The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were sold in multiple transactions at prices ranging from $3.38 to $5.21, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price such shares were sold.

Footnote F2

The reported transactions are matchable transactions subject to Section 16(b) of the Securities Exchange Act of 1934. The reporting person has calculated a short-swing profit in connection with such matchable transactions, which the reporting person intends to disgorge to the Issuer.

Footnote F3

The price reported in Column 4 is a weighted average price, rounded to the nearest cent. These shares were purchased in multiple transactions at prices ranging from $3.53 to $3.91, rounded to the nearest cent, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price such shares were purchased.

Footnote F4

The price reported in Column 8 is a weighted average price. These Call Options were purchased in multiple transactions at prices ranging from $0.4998 to $0.55, inclusive. Mr. Chernett undertakes to provide the Issuer and any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Call Options purchased at each separate price such Call Options were purchased.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .